p27^Kip1 Inhibition of GRB2-SOS Formation Can Regulate Ras Activation

REFERENCES

• Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of MAP kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 27489–27494.
   PubMed Web of Science ®Google Scholar
• Barbacid, M. 1990. Ras oncogenes: their role in neoplasia. Eur. J. Clin. Investig. 20: 225–235.
   PubMed Web of Science ®Google Scholar
• Bar-Sagi, D., D. Rotin, A. Batzer, V. Mandiyan, and J. Schlessinger. 1993. SH3 domains direct cellular localization of signaling molecules. Cell 74: 83–91.
   PubMed Web of Science ®Google Scholar
• Boussiotis, V. A., G. J. Freeman, P. A. Taylor, A. Berezovskaya, I. Grass, B. R. Blazar, and L. M. Nadler. 2000. P27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat. Med. 6: 290–296.
   PubMedGoogle Scholar
• Buday, L., P. H. Warne, and J. Downward. 1995. Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos. Oncogene 11: 1327–1331.
   PubMed Web of Science ®Google Scholar
• Catzavelos, C., M. Tsao, G. DeBoer, N. Bhattacharya, F. A. Shephard, and J. M. Slingerland. 1999. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res. 59: 684–688.
   PubMed Web of Science ®Google Scholar
• Chardin, P., J. H. Camonis, N. W. Gale, L. Van Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260: 1338–1343.
   PubMed Web of Science ®Google Scholar
• Cheng, A. M., T. M. Saxton, R. Sakai, S. Kulkarni, G. Mbamalu, W. Vogel, C. G. Tortorice, R. D. Cardiff, J. C. Cross, W. J. Muller, and T. Pawson. 1998. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95: 793–803.
   PubMed Web of Science ®Google Scholar
• Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21Cip1 and p27Kip1 CDK ‘inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571–1583.
   PubMed Web of Science ®Google Scholar
• Cherniak, A. D., J. K. Klarlund, B. R. Conway, and M. P. Czech. 1995. Disassembly of Son-of-sevenless proteins from Grb2 during p21 ras desensitization. J. Biol. Chem. 270: 1485–1488.
   PubMedGoogle Scholar
• Clurman, B., and J. M. Roberts. 1998. Cell cycle control: an overview, p. 175–193. In B. Vogelstein and K. W. Kinzler (ed.), The genetic basis of human cancer, 1st ed. McGraw-Hill, New York, N.Y.
   Google Scholar
• Coats, S., W. M. Flannagan, J. Nourse, and J. Roberts. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877–880.
   PubMed Web of Science ®Google Scholar
• Coats, S., P. Whyte, M. L. Fero, S. Lacy, G. Chung, E. Randel, E. Firpo, and J. M. Roberts. 1999. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27Kip1-deficient cells. Curr. Biol. 9: 163–173.
   PubMedGoogle Scholar
• Corbolan-Garcia, S., S.-S. Yang, K. R. Degenhardt, and D. Bar-Sagi. 1996. Identification of the MAP kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol. Cell. Biol. 10: 5674–5682.
   Google Scholar
• Daly, R. J., M. D. Binder, and R. L. Sutherland. 1994. Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 9: 2723–2727.
   PubMed Web of Science ®Google Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
   PubMed Web of Science ®Google Scholar
• Dobrowolski, S., M. Harter, and D. W. Stacey. 1994. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14: 5441–5449.
   PubMedGoogle Scholar
• Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the MAP kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686–7689.
   PubMed Web of Science ®Google Scholar
• Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of SOS Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 45–51.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E. 2000. Relationship between Ras pathways and cell cycle control. Progress Cell Cycle Res. 4: 1–17.
   PubMedGoogle Scholar
• Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell 85: 733–744.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., E. Randel, K. E. Gurley, J. M. Roberts, and C. J. Kemp. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396: 177–180.
   PubMed Web of Science ®Google Scholar
• Frame, S., and A. Balmain. 2000. Integration of positive and negative growth signals during ras pathway activation in vivo. Curr. Opin. Genet. Dev. 10: 106–113.
   PubMedGoogle Scholar
• Fredersdorf, S., J. Burns, A. M. Milne, G. Packham, L. Fallis, C. E. Gillett, J. A. Royds, D. Peston, P. A. Hall, A. M. Hanby, D. M. Barnes, S. Shousha, M. J. O'Hare, and X. Lu. 1997. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA 94: 6380–6385.
   PubMed Web of Science ®Google Scholar
• Gille, H., and J. Downward. 1999. Multiple Ras effector pathways contribute to G1 cell cycle progression. J. Biol. Chem. 274: 22033–22038.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Heldin, C., and B. Westermark. 1999. Mechanism of action and in vivo role of PDGF. Phys. Rev. 79: 1283–1316.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed. 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91: 5291–5295.
   PubMed Web of Science ®Google Scholar
• Howell, K. E., E. Devaney, and J. Gruenberg. 1989. Subcellular fractionation of tissue culture cells. Trends Biol. Sci. 14: 44–47.
   PubMedGoogle Scholar
• Ishida, N., T. Hara, T. Kamura, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277: 14355–14358.
   PubMed Web of Science ®Google Scholar
• Ishida, N., M. Kitagawa, S. Hatakeyama, and K. Nakayama. 2000. Phosphorylation at serine 10, a major phosphorylation site of p27Kip1, increases its protein stability. J. Biol. Chem. 275: 25146–25154.
   PubMed Web of Science ®Google Scholar
• Katz, M. E., and F. McCormick. 1997. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7: 75–79.
   PubMed Web of Science ®Google Scholar
• Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85: 721–732.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyack, J. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by transforming growth factor beta. Science 260: 536–539.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of inhibitors. Genes Dev. 11: 847–862.
   PubMed Web of Science ®Google Scholar
• Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18: 6605–6615.
   PubMed Web of Science ®Google Scholar
• Langlois, W. J., T. Sasaoka, A. R. Saltiel, and J. M. Olefsky. 1995. Negative feedback regulation and desensitization of insulin- and EGF-stimulated p21ras activation. J. Biol. Chem. 270: 25320–25323.
   PubMed Web of Science ®Google Scholar
• Li, W., C. D. Whaley, A. Mondino, and D. L. Mueller. 1996. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 271: 1272–1276.
   PubMed Web of Science ®Google Scholar
• Li, N., A. Batzer, R. Daly, V. Yajkik, E. Skolnik, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363: 85–88.
   PubMed Web of Science ®Google Scholar
• Lloyd, R. V., L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer. 1999. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154: 313–323.
   PubMed Web of Science ®Google Scholar
• Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431–442.
   PubMed Web of Science ®Google Scholar
• Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. VandeWoude, and N. G. Ahn. 1994. Transformation of mammalian cells by consitutively active MAP kinase kinase. Science 265: 966–970.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13: 261–291.
   PubMed Web of Science ®Google Scholar
• Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313: 241–243.
   PubMed Web of Science ®Google Scholar
• Muller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers. 1997. CDK2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclinE/cdk2 complexes. Oncogene 15: 2561–2576.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, D. Y. Loh, and K. Nakayama. 1996. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707–720.
   PubMed Web of Science ®Google Scholar
• Nourse, J., E. Firpo, M. Flanagan, M. Meyerson, K. Polyak, M. H. Lee, J. Massague, G. Crabtree, and J. Roberts. 1994. IL-2 mediated elimination of the p27kip1 cyclin-CDK kinase inhibitor prevented by rapamycin. Nature 372: 570–573.
   PubMed Web of Science ®Google Scholar
• Olivier, J. P., T. Raabe, M. Henkenmeyer, B. Dickson, G. Mbamalu, B. Margolis, J. Schlessinger, E. Hafen, and T. Pawson. 1993. A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of ras guanine nucleotide exchange, Sos. Cell 73: 179–191.
   PubMed Web of Science ®Google Scholar
• Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682–685.
   PubMed Web of Science ®Google Scholar
• Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177–181.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27kip1, a cyclin-CDK inhibitor, links transforming growth factor beta and contact inhibition to cell cycle arrest. Genes Dev. 8: 9–22.
   PubMed Web of Science ®Google Scholar
• Rodier, G., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G. F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser 10 and is not a prerequisite for its proteolysis. EMBO J. 20: 6672–6682.
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360: 689–692.
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato, M., F. I. Camacho, J. C. Martinez-Montero, A. I. Saez, R. Villuendas, L. Sanchez-Verde, J. F. Garcia, and M. A. Piris. 1999. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 94: 765–772.
   PubMed Web of Science ®Google Scholar
• Satoh, T., M. Endo, M. Nakafuku, S. Nakamura, and Y. Kaziro. 1990. Platelet-derived growth factor stimulates formation of active p21ras-GTP complex in Swiss mouse 3T3 cells. Proc. Natl. Acad. Sci. USA 87: 5993–5997.
   PubMed Web of Science ®Google Scholar
• Satoh, T., M. Endo, M. Nakafuku, T. Akiyama, T. Yamamoto, and Y. Kaziro. 1990. Accumulation of p21ras-GTP in response to stimulation with EGF and oncogene products with tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 87: 7926–7929.
   PubMed Web of Science ®Google Scholar
• Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9: 351–357.
   PubMed Web of Science ®Google Scholar
• Sgambato, A., A. Cittadini, B. Faraglia, and I. B. Weinstein. 2000. Multiple functions of p27Kip1 and its alterations in tumor cells: a review. J. Cell. Phys. 183: 18–27.
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11: 1464–1478.
   PubMed Web of Science ®Google Scholar
• Sherr, C., and J. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1153.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13: 1501–1512.
   PubMed Web of Science ®Google Scholar
• Shields, J. M., K. Pruitt, A. McFall, A. Shaub, and C. J. Der. 2000. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 10: 147–154.
   PubMed Web of Science ®Google Scholar
• Simon, M. A., G. S. Dodson, and G. M. Rubin. 1993. An SH3-SH2-SH3 protein is required for p21Ras1 activation and binds to sevenless and Sos protein in vitro. Cell 73: 169–177.
   PubMed Web of Science ®Google Scholar
• Singh, S. P., J. Lipman, H. Goldman, F. H. Ellis, Jr, L. Aizenman, M. G. Cangi, S. Signoretti, D. S. Chiaur, M. Pagano, and M. Loda. 1998. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58: 1730–1735.
   PubMed Web of Science ®Google Scholar
• Smitherman, M., K. Lee, J. Swanger, R. Kapur, and B. E. Clurman. 2000. Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol. Cell. Biol. 20: 5631–5642.
   PubMed Web of Science ®Google Scholar
• Sugiyama, Y., K. Tomoda, T. Tanaka, Y. Arata, N. Yoneda-Kato, and J. Kato. 2001. Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1. J. Biol. Chem. 276: 12084–12090.
   PubMed Web of Science ®Google Scholar
• Sweeney, K. J., A. Swarbrick, R. L. Sutherland, and E. A. Musgrove. 1998. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 16: 2865–2878.
   PubMed Web of Science ®Google Scholar
• Takuwa, N., and Y. Takuwa. 1997. Ras activity late in G1 phase required for p27Kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17: 5348–5358.
   PubMed Web of Science ®Google Scholar
• Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6: 1621–1627.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160–165.
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1-cyclin-CDK protein kinase activity, is related to p21. Cell 78: 67–74.
   PubMed Web of Science ®Google Scholar
• Tsihlias, J., L. Kapusta, and J. Slingerland. 1999. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50: 401–423.
   PubMed Web of Science ®Google Scholar
• Verbeek, B. S., S. S. Adriaansen-Slot, G. Rijksen, and T. M. Vroom. 1997. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J. Pathol. 183: 195–203.
   PubMed Web of Science ®Google Scholar
• Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16: 5334–5344.
   PubMed Web of Science ®Google Scholar
• Waters, S. B., K. Yamauchi, and J. E. Pessin. 1995. Insulin-stimulated dissociation of the Sos-Grb2 complex. Mol. Cell. Biol. 15: 2791–2799.
   PubMedGoogle Scholar
• Zarich, N., J. L. Oliva, R. Jorge, E. Santos, and J. M. Rojas. 2000. The isoform-specific stretch of hSos1 defines a new Grb2-binding domain. Oncogene 19: 5872–5883.
   PubMedGoogle Scholar
• Zeng, Y., K. Hirano, M. Hirano, J. Nishimura, and H. Kanaide. 2000. Minimal requirements for the nuclear localization of p27Kip1, a cyclin-dependent kinase inhibitor. Biochem. Biophys. Res. Commun. 274: 37–42.
   PubMed Web of Science ®Google Scholar